| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea; 2 Research Institute, National Cancer Center, Goyang, Gyeonggi, Korea; and 3 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts
Requests for reprints: Chang-Woo Lee, Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea. Phone: 82-31299-6121; Fax: 82-31299-6269; E-mail: cwlee{at}med.skku.ac.kr.
The mitotic spindle checkpoint plays a crucial role in regulating accurate chromosome segregation and preventing the adaptation of multiploid progeny cells. Recent reports have indicated that the induction of p53 by mitotic checkpoint activation is essential for protecting cells from abnormal chromosome ploidization caused by mitotic failure. However, although studies have shown that p53 deficiencies arrest mitosis, compromise apoptosis, and may cause profound aneuploidy, the molecular mechanisms leading to p53 induction following mitotic checkpoint activation remain unknown. Here, we show that the BubR1 mitotic checkpoint kinase interacts with p53 both in vitro and in vivo, with higher levels of interaction in mitotic cells. This interaction contributes to p53 phosphorylation. Silencing of BubR1 expression reduces the phosphorylation and stability of p53, whereas exogenous introduction of BubR1 proteins into BubR1-depleted cells recovers p53 stability. In addition, inhibition of BubR1 expression in the presence of a microtubule inhibitor accelerates chromosomal instability and polyploidy in p53-null cells. These results collectively suggest that p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation. [Cancer Res 2007;67(15):7155–64]
This article has been cited by other articles:
![]() |
A-W Liu, J Cai, X-L Zhao, A-M Xu, H-q Fu, H Nian, and S-H Zhang The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma J. Clin. Pathol., November 1, 2009; 62(11): 1003 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Huang, M. D.-T. Chang, and S.-Y. Shieh TTK/hMps1 Mediates the p53-Dependent Postmitotic Checkpoint by Phosphorylating p53 at Thr18 Mol. Cell. Biol., June 1, 2009; 29(11): 2935 - 2944. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tomasini, K. Tsuchihara, C. Tsuda, S. K. Lau, M. Wilhelm, A. Ruffini, M.-s. Tsao, J. L. Iovanna, A. Jurisicova, G. Melino, et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity PNAS, January 20, 2009; 106(3): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Kim, Y.-K. Jeon, G.-H. Ha, H.-Y. Park, Y.-J. Kim, H.-J. Shin, C. G. Lee, D.-H. Chung, and C.-W. Lee Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/CyclosomeCdc20-Independent Manner Cancer Res., January 1, 2009; 69(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Storchova and C. Kuffer The consequences of tetraploidy and aneuploidy J. Cell Sci., December 1, 2008; 121(23): 3859 - 3866. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng, Z. Shen, J. Yang, S.-H. Lu, and Y. Cui ECRG2 Disruption Leads to Centrosome Amplification and Spindle Checkpoint Defects Contributing Chromosome Instability J. Biol. Chem., February 29, 2008; 283(9): 5888 - 5898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |